Europe Research Roundup: Dechra Pharmaceuticals, Keller Group, ThyssenKrupp

Centiel AG

24/08/2020 07:51

Aug 24 (Reuters) - Securities analysts revised their ratings and price targets on several
European companies, including Dechra Pharmaceuticals, Keller Group and ThyssenKrupp on Monday. 
    
    HIGHLIGHTS
     * Dechra Pharmaceuticals Plc  DPH.L : Liberum starts with sell rating; target price 2740p
     * Keller Group Plc  KLR.L : Jefferies cuts to hold from buy
     * ThyssenKrupp  TKAG.DE : Deutsche Bank resumes coverage with rating hold
      
Following is a summary of research actions on European companies reported by Reuters on Monday.
Stock entries are in alphabetical order. See bottom of the table for sector changes.  
    
     * Adyen NV  ADYEN.AS : Jefferies raises target price to EUR 1608 from EUR 1495
     * Beazley  BEZG.L : Peel Hunt raises target price to 375p from 340p
     * CVS Group Plc  CVSG.L : Liberum starts with hold rating; target price 1274p
     * Dechra Pharmaceuticals Plc  DPH.L : Liberum starts with sell rating; target price 2740p
     * Flughafen Zuerich AG  FHZN.S : RBC raises target price to CHF 145 from CHF 140
     * Hochdorf Holding AG  HOCN.S : Credit Suisse cuts target price to CHF 55 from CHF 65
     * Keller Group Plc  KLR.L : Jefferies cuts to hold from buy
     * Keller Group Plc  KLR.L : Jefferies raises target price to 640p from 590p
     * Kingspan Group Plc  KSP.I : Jefferies raises target price to EUR 68.50 from EUR 55.70
     * Talktalk  TALK.L : Credit Suisse cuts target price to 80p from 90p
     * ThyssenKrupp  TKAG.DE : Deutsche Bank resumes coverage with rating hold
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))